ClinicalTrials.gg
CompletedNCT03096977Updated Apr 17, 2019

Use of the Nine Holes Peg Test in Multiple Sclerosis: Participation of Elementary Neurological Components in the Functional Evaluation of Manual Dexterity

An interventional study of Scale for the assessment and rating of ataxia (SARA) and JAMAR hand dynamometer in Multiple Sclerosis, sponsored by Brugmann University Hospital. Completed at 1 site in Belgium. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2019-04-17.

Sponsored by Brugmann University Hospital · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
20 Years to 60 Years
Sex
All
01

Study summary

This study lies in the continuity of the study with identification number NCT02805634. It will be performed on the same group of patients and will aim to assess the manual dexterity, in order to better assign kinesitherapy treatments and increase the utilisation capacity of the hand.

02

Conditions studied

  • Multiple Sclerosis

Browse trials for

Keywords

  • Hand dexterity
  • Multiple sclerosis
  • Nine Holes Peg
03

In context

Multiple Sclerosis

3,524 studies on the registry are indexed under Multiple Sclerosis; 668 are open to participants now.

This study's enrollment of 30 is below the median of 50 across 2,386 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Brugmann University Hospital is the lead sponsor of 117 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients included in the NCT02805634 study

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    CHUB-TST02 patients

    All patients who participated in the NCT02805634 (CHUB-TST02) study.

    Diagnostic Test: Scale for the assessment and rating of ataxia (SARA) · Device: JAMAR hand dynamometer · Device: Vibratory sensibility testing · Device: Sermes and Weinstein test · Device: Weber test

Interventions

  • Diagnostic testScale for the assessment and rating of ataxia (SARA)

    Clinical evaluation of the manual dexterity through the SARA scale.

  • DeviceJAMAR hand dynamometer

    Clinical evaluation of the prehension force using a JAMAR Dynamometer. The prehension effort is made with the arm along the body, forearm horizontal, elbow flexed at 90 degrees, wrist in neutral position. The handle of the dynamometer is set to the second notch. The effort required is maximum effort. Verbal encouragement is given during four successive tentative: the last three are averaged. Each effort will be separated by a rest period of one minute. Interval: 1 min - Repeat: 3 times per hand

  • DeviceVibratory sensibility testing

    Test carried out using a tuned fork applied to the styloid radial process. Position of the evaluated: elbow to the body with forearms horizontal and the wrist in neutral position. Stimulate the tuning fork and apply it to the styloid process of the radius. Ask the patient to say when he no longer feels the vibration. Repeat 3 times for each hand.

  • DeviceSermes and Weinstein test

    Instrumental, quantitative method of tactile pressure sensation (dermal contact at constant pressure) using monofilaments. The monofilaments bend when a threshold force is applied to them.There is a kit of 5 monofilaments, each one corresponding to a different functional level. Familiarize the patient with the test, eyes open, on a normal healthy side. Determine the level of perception of the healthy side, eyes closed. Start with the finest monofilament. If the answer is negative, go to the next monofilament. The monofilaments applications are randomly made in the Wynn Parry areas, 3 times / area for blue and green filaments, then 1 time / zone for others. The monofilament must be applied in 1.5 sec, held 1.5 sec, removed in 1.5 sec. The patient must give a verbal response "yes" when he perceives the contact and the response time must be less than 3 sec.

  • DeviceWeber test

    Evaluate the discrimination of 2 motionless points. The tactile discrimination threshold is the smallest distance separating 2 simultaneous stimulations that are located and perceived separately. The pressure stops at the whitening of the skin. The patient should specify if he feels one or two spikes. To determine the discrimination threshold: Perform 10 stimulations of the same spacing in the same area. The smallest interval for which 7 correct answers are obtained is retained as threshold value. Perform the test 3 times.

06

What researchers measure

Primary outcomes

  1. Scale for the assessment and rating of ataxia (SARA)

    Scale for the assessment and rating of ataxia (SARA)

    Time frame: 1 year

  2. Prehension force

    Prehension force, using a JAMAR hand dynamometer

    Time frame: 1 year

  3. Tuned fork result

    Vibratory sensibility testing

    Time frame: 1 year

  4. Sermes and Weinstein test

    Tactile pressure sensation testing

    Time frame: 1 year

  5. Weber test

    Evaluate the discrimination of 2 motionless points

    Time frame: 1 year

07

Study locations

1 site
  • CHU Brugmann
    Brussels, 1020, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03096977
Responsible party
Bernard Dachy (Head of Clinic, Brugmann University Hospital) — Principal investigator
First posted
Mar 31, 2017
Start date
Mar 15, 2017
Primary completion
Jan 30, 2019
Completion
Jan 30, 2019
Last update
Apr 17, 2019

Study contacts

Bernard Dachy, MD
principal investigator · CHU Brugmann

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion